These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29107349)

  • 1. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
    Cheng H; Peng J; Yang Z; Zhang G
    Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.
    Nasioudis D; Kanninen TT; Holcomb K; Sisti G; Witkin SS
    Gynecol Oncol; 2017 May; 145(2):243-247. PubMed ID: 28292524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?
    Brown J; Sood AK; Deavers MT; Milojevic L; Gershenson DM
    Gynecol Oncol; 2009 Apr; 113(1):86-90. PubMed ID: 19162310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor: a systematic review of literature.
    Blake EA; Carter CM; Kashani BN; Kodama M; Mabuchi S; Yoshino K; Matsuo K
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():1-7. PubMed ID: 24439718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility sparing surgery for ovarian sex cord stromal tumors: a nine case series.
    Ghalleb M; Bouzaiene H; Sghaier S; Bouaziz H; Hechiche M; Hassouna JB; Rahal K
    Pan Afr Med J; 2018; 31():221. PubMed ID: 31447979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary.
    Nasioudis D; Frey MK; Chapman-Davis E; Witkin SS; Holcomb K
    Int J Gynecol Cancer; 2017 Nov; 27(9):1826-1832. PubMed ID: 28930803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review.
    Kleppe M; Amkreutz LC; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
    Gynecol Oncol; 2014 Apr; 133(1):124-7. PubMed ID: 24440833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
    Wang J; Chen R; Li J; Lu X
    Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
    Hanvic B; Lecuru F; Vanacker H; Pautier P; Narducci F; Cherifi F; Floquet A; Angeles MA; Berton D; Pomel C; Kalbacher E; Provansal M; Fernandez Y; Rouge TM; Roméo C; Laas E; Morice P; Hudry D; Meriaux E; Guyon F; Illac-Vauquelin C; Selle F; Meeus P; Genestie C; Salleron J; Ray-Coquard I
    Gynecol Oncol; 2023 Jul; 174():190-199. PubMed ID: 37210929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.
    Klar M; Plett H; Harter P; Heitz F; Kommoss S; Hartkopf AD; Grube M; Roser E; Sehouli J; Braicu I; Czogalla B; Burges A; Bossart M; Hasanov MF; Link T; Staebler A; Mayr D; Buderath P; Hasenburg A
    J Surg Oncol; 2023 Jul; 128(1):111-118. PubMed ID: 36975108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
    Bossart M; Plett H; Krämer B; Braicu E; Czogalla B; Klar M; Singer S; Mayr D; Staebler A; du Bois A; Kommoss S; Link T; Burges A; Heitz F; Grube M; Trillsch F; Harter P; Wimberger P; Buderath P; Hasenburg A
    Arch Gynecol Obstet; 2023 Apr; 307(4):1155-1162. PubMed ID: 36127525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.